AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization.


Journal

Theranostics
ISSN: 1838-7640
Titre abrégé: Theranostics
Pays: Australia
ID NLM: 101552395

Informations de publication

Date de publication:
2020
Historique:
received: 27 07 2020
accepted: 04 10 2020
entrez: 18 11 2020
pubmed: 19 11 2020
medline: 2 6 2021
Statut: epublish

Résumé

Calcium oxalate (CaOx) crystal can trigger kidney injury, which contributes to the pathogenesis of nephrocalcinosis. The phenotypes of infiltrating macrophage may impact CaOx-mediated kidney inflammatory injury as well as crystal deposition. How aryl hydrocarbon receptor (AhR) regulates inflammation and macrophage polarization is well understood; however, how it modulates CaOx nephrocalcinosis remains unclear.

Identifiants

pubmed: 33204326
doi: 10.7150/thno.51144
pii: thnov10p12011
pmc: PMC7667681
doi:

Substances chimiques

3' Untranslated Regions 0
6-formylindolo(3,2-b)carbazole 0
AHR protein, human 0
Ahr protein, mouse 0
Basic Helix-Loop-Helix Transcription Factors 0
Carbazoles 0
Glyoxylates 0
Hif1a protein, mouse 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
Interferon Regulatory Factor-1 0
Irf1 protein, mouse 0
MicroRNAs 0
Mirn142 microRNA, mouse 0
Receptors, Aryl Hydrocarbon 0
Calcium Oxalate 2612HC57YE
glyoxylic acid JQ39C92HH6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12011-12025

Informations de copyright

© The author(s).

Déclaration de conflit d'intérêts

Competing Interests: The authors have declared that no competing interest exists.

Références

J Neuroinflammation. 2017 Mar 16;14(1):55
pubmed: 28302134
Rev Urol. 2010 Spring;12(2-3):e86-96
pubmed: 20811557
Biomed Pharmacother. 2020 Jan;121:109606
pubmed: 31743875
J Transl Med. 2018 Sep 17;16(1):257
pubmed: 30223848
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1122-6
pubmed: 22232670
Kidney Int. 2018 Mar;93(3):656-669
pubmed: 29241624
RNA. 2007 Mar;13(3):385-95
pubmed: 17237357
J Mol Biol. 1999 Jun 11;289(3):459-71
pubmed: 10356322
Nat Commun. 2016 Jan 28;7:10274
pubmed: 26817517
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15989-94
pubmed: 16236719
J Clin Invest. 2007 May;117(5):1155-66
pubmed: 17476345
Thorax. 2019 Sep;74(9):865-874
pubmed: 31331947
Theranostics. 2020 Jul 25;10(21):9561-9578
pubmed: 32863945
Lab Invest. 2019 May;99(5):671-683
pubmed: 30700847
Chem Biol Interact. 2016 Feb 25;246:30-5
pubmed: 26748311
Sci Rep. 2016 Oct 12;6:35167
pubmed: 27731368
Mol Immunol. 2007 Jan;44(4):338-46
pubmed: 16597464
Cell Commun Signal. 2020 May 4;18(1):70
pubmed: 32366266
Redox Biol. 2015 Aug;5:398-408
pubmed: 26163808
BJU Int. 2017 Jul;120(1):109-116
pubmed: 28236332
Nature. 2013 Apr 11;496(7444):238-42
pubmed: 23535595
J Bone Miner Res. 2010 Dec;25(12):2701-11
pubmed: 20577968
J Histochem Cytochem. 1964 May;12:333-6
pubmed: 14193854
EBioMedicine. 2019 Dec;50:366-378
pubmed: 31735555
Nat Commun. 2015 Oct 05;6:8523
pubmed: 26436920
Curr Opin Clin Nutr Metab Care. 2003 Mar;6(2):223-8
pubmed: 12589193
Chin Med J (Engl). 2002 Dec;115(12):1833-7
pubmed: 12622934
Annu Rev Immunol. 2014;32:403-32
pubmed: 24655296
Nat Rev Immunol. 2003 Jan;3(1):23-35
pubmed: 12511873
J Am Soc Nephrol. 2014 Aug;25(8):1680-97
pubmed: 24578130
J Urol. 2015 Dec;194(6):1787-96
pubmed: 26192255
FASEB J. 2019 Apr;33(4):5208-5219
pubmed: 30624969
Immunity. 2014 Jun 19;40(6):989-1001
pubmed: 24909886
J Am Soc Nephrol. 1999 Nov;10(11):2323-31
pubmed: 10541291
Trends Immunol. 2004 Dec;25(12):677-86
pubmed: 15530839
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14222-7
pubmed: 21825138
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1023-9
pubmed: 18667485
Nat Commun. 2014 Aug 20;5:4738
pubmed: 25141024
Br J Pharmacol. 1996 Aug;118(8):2178-84
pubmed: 8864559
Biochem Pharmacol. 2000 Apr 15;59(8):997-1005
pubmed: 10692565
J Biol Chem. 2005 May 27;280(21):20340-8
pubmed: 15790560
Hypertension. 2015 Jul;66(1):75-84
pubmed: 25987665
BMC Nephrol. 2020 Jul 13;21(1):270
pubmed: 32660446
Genes Dev. 2010 Mar 1;24(5):491-501
pubmed: 20194441
Gastroenterology. 2011 Jul;141(1):237-48, 248.e1
pubmed: 21600206
Adv Chronic Kidney Dis. 2017 Mar;24(2):57-63
pubmed: 28284380
Urol Res. 2007 Apr;35(2):89-99
pubmed: 17393196
Theranostics. 2020 Jun 5;10(16):7319-7334
pubmed: 32641994
J Clin Invest. 2013 Jan;123(1):236-46
pubmed: 23221343
Annu Rev Immunol. 2016 May 20;34:173-202
pubmed: 26772211
Pediatr Nephrol. 2010 May;25(5):831-41
pubmed: 19198886
Clin Nucl Med. 2017 Feb;42(2):112-113
pubmed: 27879491
Nat Rev Nephrol. 2019 Apr;15(4):220-239
pubmed: 30651611
J Exp Med. 2009 Aug 31;206(9):2027-35
pubmed: 19703987
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16001-6
pubmed: 16243976
J Immunol Res. 2018 Jan 14;2018:8917804
pubmed: 29507865
Biochem Pharmacol. 2018 Sep;155:494-509
pubmed: 30071202
J Nucl Med. 2001 Oct;42(10):1551-5
pubmed: 11585872
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F137-F151
pubmed: 31091119
J Biol Chem. 1997 May 2;272(18):12236-43
pubmed: 9115299
Biochemistry (Mosc). 2012 Mar;77(3):246-60
pubmed: 22803942
Front Immunol. 2019 Apr 17;10:799
pubmed: 31057539
Sci Rep. 2017 Aug 18;7(1):8801
pubmed: 28821730
J Urol. 2014 Jun;191(6):1906-12
pubmed: 24518782
Life Sci. 2016 Jun 15;155:76-84
pubmed: 27153778
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2849-54
pubmed: 17293456
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Nutr Rev. 2013 Jun;71(6):353-69
pubmed: 23731446
J Bone Miner Res. 2009 May;24(5):908-24
pubmed: 19113933
Am J Kidney Dis. 1999 Apr;33(4):761-71
pubmed: 10196021
Kidney Int. 2002 Jan;61(1):105-12
pubmed: 11786090
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Nat Rev Nephrol. 2019 Aug;15(8):501-520
pubmed: 31164720

Auteurs

Xiaoqi Yang (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Haoran Liu (H)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Tao Ye (T)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Chen Duan (C)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Peng Lv (P)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiaoliang Wu (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Jianhe Liu (J)

Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Kehua Jiang (K)

Department of Urology, Guizhou Provincial People's Hospital, Guiyang, China.

Hongyan Lu (H)

Department of Urology, The Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Huan Yang (H)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Ding Xia (D)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Ejun Peng (E)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zhiqiang Chen (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Kun Tang (K)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zhangqun Ye (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH